Labs / Assays & in vitro testing
Domainex
Essex, United Kingdom · domainex.co.uk
Domainex is a contract research organisation that provides integrated drug discovery services for life science organisations. It works on preclinical drug discovery projects for clients across the world from Cambridge, UK.
They take quote requests by email.
What they offer
Integrated Drug Discovery
Provides end-to-end preclinical drug discovery support across multiple stages of a project.
Lead Discovery
Supports discovery efforts to identify and progress initial leads.
Hit to Lead
Advances hit compounds toward lead series through iterative optimisation.
Hit Identification
Offers hit-finding and screening support to identify starting compounds.
Lead Optimisation
Supports optimisation of lead compounds to improve project properties.
Project Management and Consultancy Services
Provides project management and scientific consultancy support for discovery programmes.
Structure Based Drug Design (SBDD)
Uses structural information to guide design of new compounds.
Virtual Screening
Uses computational methods to screen compound libraries in silico.
High Throughput Screening (HTS)
Performs high-throughput screening to identify active compounds.
Fragment Screening
Screens fragment libraries to find low-molecular-weight starting points.
PureDisc™ Enabled Membrane Protein Production
Produces membrane proteins in a native phospholipid environment for downstream studies.
Assay Development and Transfer
Develops and transfers biophysical, biochemical and cell-based assays.
Biochemistry / Enzymology
Develops biochemical and enzymatic assays for target activity assessment.
Biomarker Services
Provides biomarker discovery and translational assessment support.
Biophysics
Applies biophysical methods to study targets and compound interactions.
Cell-Based Assays
Develops and runs assays using cells to assess compound effects.
Protein Expression
Expresses proteins for use in discovery and assay work.
Structural Biology
Supports structure determination and structural studies for drug discovery.
X-ray Crystallography
Uses X-ray crystallography for structure-based discovery and analysis.
DMPK Services
Provides drug metabolism and pharmacokinetics support for discovery programmes.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Recombinant protein
- Species and models
- Caco-2, MDCK, plasma
- Assays and studies
- assay development, assay transfer, biochemical assays, enzyme assays, kinetic assays, biomarker discovery, biophysical assays, cell-based assays, high-throughput screening, fragment screening, virtual screening, lead optimisation assays, and 3 more
- Instruments and platforms
- Surface Plasmon Resonance (SPR), Grating Coupled Interferometry (GCI), Isothermal Titration Calorimetry (ITC), Differential Scanning Fluorimetry (DSF), nanoDSF, Dynamic Light Scattering (DLS), Mass Photometry, Spectral Shift, MST, Flow Cytometry, Cryo-EM, X-ray Crystallography
- Therapeutic areas
- anti-infectives, cardiovascular, CNS, immuno-oncology, inflammatory diseases, oncology, respiratory, neuroinflammation, fibrosis
- Type
- CRO
- Sites
- Cambridge, United Kingdom
- Quality
- multi-award winning
- Address
- 40 South Street Unity Campus Pampisford Cambridge CB22 3FW UK Travelling by car Chemi
- Founded
- 2008
Public records
- Ownership
- DOMAINEX LIMITED · GB GLEIF
Similar labs. Biofidus GmbH, EyeCRO, MedChem Partners, Novalix
Found in a contract services directory. Listing built from domainex.co.uk. Work here? Claim this listing.